Mycophenolate mofetil (MMF) is an immunosuppressive drug the efficiency of which has been established in renal transplantation. Recent studies suggest that it may also be effective in the treatment of variant skin diseases especially if the skin lesions are triggered by lymphocytes. Studies have shown efficacy in autoimmune bullous dermatoses, atopic dermatitis and psoriasis. However, there are no placebo-controlled trials that support the use of MMF as first line therapy in these skin diseases.
EpinetteWW, ParkerCM, JonesEL, GreistMC.Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety.J Am Acad Dermatol1987; 17: 962–971.
MimouniD, AnhaltGJ, CumminsDL, KoubaDJ, ThorneJE, NousariHC.Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.Arch Dermatol2003; 139: 739–742.
4.
PowellAM, AlbertS, Al FaresS. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.Br J Dermatol2003; 149: 138–145.
5.
EnkAH, KnopJ.Treatment of pemphigus vulgaris with mycophenolate mofetil.Lancet1997; 350: 494.
6.
EnkAH, KnopJ.Mycophenolate is effective in the treatment of pemphigus vulgaris.Arch Dermatol1999; 135: 54–56.
7.
NousariHC, SragovichA, Kimyai-AsadiA, OrlinskyD, AnhaltGJ.Mycophenolate mofetil in autoimmune and inflammatory skin disorders.J Am Acad Dermatol1999; 40: 265–268.
8.
Grundmann-KollmannM, KortingHC, BehrensS. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.J Am Acad Dermatol1999; 40: 957–960.
9.
WilliamsJV, MarksJGJr, BillingsleyEM.Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.Br J Dermatol2000; 142: 506–508.
10.
Chams-DavatchiC, NonahalAR, DaneshpazoohM. Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris.Ann Dermatol Venereol2002; 129: 23–25.
11.
KatzKH, MarksJGJr, HelmKF.Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.J Am Acad Dermatol2000; 42: 514–515.
NousariHC, GriffinWA, AnhaltGJ.Successful therapy for bullous pemphigoid with mycophenolate mofetil.J Am Acad Dermatol1998; 39: 497–498.
16.
RatnamKV.Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.Singapore Med J2001; 42: 482–484.
17.
MegahedM, SchmiedebergS, BeckerJ, RuzickaT.Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.J Am Acad Dermatol2001; 45: 256–259.
18.
ElserI, SelimovicD, RuzickaT, KuhnA, MegahedM.Mycophenolate mofetil as effective therapy option in scarring pemphigoid.Hautarzt2003; 54: 981–984.
19.
GlaserR, SticherlinM.Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil.Acta Derm Venereol2002; 82: 308–309.
20.
Farley-LiJ, ManciniAJ.Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil.Arch Dermatol2003; 139: 1121–1124.
SchattenkirchnerS, EmingS, HunzelmannN, KriegT, SmolaH.Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting.Br J Dermatol1999; 141: 932–933.
23.
TrebingD, ZiemerA.Acquired epidermolysis bullosa with a highly varied clinical picture and successful treatment with mycophenolate mofetil.Hautarzt2001; 52: 717–721.
JonesEL, EpinetteWW, HackneyVC, MenendezL, FrostP.Treatment of psoriasis with oral mycophenolic acid.J Invest Dermatol1975; 65: 537–542.
26.
MarinariR, FleischmajerR, SchraggerAH, RosenthalAL.Mycophenolic acid in the treatment of psoriasis: long-term administration.Arch Dermatol1977; 113: 930–932.
27.
LynchWS, RoenigkHHJr. Mycophenolic acid for psoriasis.Arch Dermatol1977; 113: 1203–1208.
ZhouY, RosenthalD, DutzJ, HoV.Mycophenolate Mofetil (CellCept(R)) for Psoriasis: A Two-Center, Prospective, Open-Label Clinical Trial.J Cutan Med Surg2003; 7: 193–197.
30.
GeilenCC, ArnoldM, OrfanosCE.Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.Br J Dermatol2001; 144: 583–586.
31.
DavisonSC, Morris-JonesR, PowlesAV, FryL.Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.Br J Dermatol2000; 143: 405–407.
32.
DaudenE, Sanchez-PeinadoC, Ruiz-GenaoD, GarciaFV, OnateMJ, Garcia-DiezA.Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.Br J Dermatol2004; 150: 132–135.
33.
AmeenM, SmithHR, BarkerJN.Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis.Clin Exp Dermatol2001; 26: 480–483.
34.
GeilenCC, TebbeB, GarciaBC, KrengelS, OrfanosCE.Successful treatment of erythrodermic psoriasis with mycophenolate mofetil.Br J Dermatol1998; 138: 1101–1102.
35.
Grundmann-KollmannM, MooserG, SchraederP. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.J Am Acad Dermatol2000; 42: 835–837.
WohlrabJ, JahnK, PlaetzerM, NeubertR, MarschWC.Topical application of mycophenolate mofetil in plaque-type psoriasis.Br J Dermatol2001; 144: 1263–1264.
38.
NeuberK, SchwartzI, ItschertG, DieckAT.Treatment of atopic eczema with oral mycophenolate mofetil.Br J Dermatol2000; 143: 385–391.
39.
Grundmann-KollmannM, KortingHC, BehrensS. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil.Br J Dermatol1999; 141: 175–176.
40.
Grundmann-KollmannM, PoddaM, OchsendorfF, BoehnckeWH, KaufmannR, ZollnerTM.Mycophenolate mofetil is effective in the treatment of atopic dermatitis.Arch Dermatol2001; 137: 870–873.
41.
HansenER, BuusS, DeleuranM, AndersenKE.Treatment of atopic dermatitis with mycophenolate mofetil.Br J Dermatol2000; 143: 1324–1326.
42.
BenezA, FierlbeckG.Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil.Br J Dermatol2001; 144: 638–639.
43.
AduD, CrossJ, JayneDR. Treatment of systemic lupus erythematosus with mycophenolate mofetil.Lupus2001; 10: 203–208.
44.
RiskallaMM, SomersEC, FaticaRA, McCuneWJ.Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.J Rheumatol2003; 30: 1508–1512.
45.
GaubitzM, SchoratA, SchotteH, KernP, DomschkeW.Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.Lupus1999; 8: 731–736.
46.
SchanzS, UlmerA, RassnerG, FierlbeckG.Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.Br J Dermatol2002; 147: 174–178.
47.
GoyalS, NousariHC.Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.J Am Acad Dermatol2001; 45: 142–144.
NousariHC, LynchW, AnhaltGJ, PetriM.The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.Arch Dermatol1998; 134: 1509–1511.
50.
HohenleutnerU, MohrVD, MichelS, LandthalerM.Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.Lancet1997; 350: 1748.
51.
MichelS, HohenleutnerU, MohrV, LandthalerM.Therapy-resistant pyoderma gangrenosum - treatment with mycophenolate mofetil and cyclosporine A.Hautarzt1999; 50: 428–431.
52.
WollinaU, KaramfilovT.Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix.J Eur Acad Dermatol Venereol2000; 14: 187–190.
53.
BuscaA, SarogliaEM, LaninoE. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation.Bone Marrow Transplant2000; 25: 1067–1671.
54.
BasaraN, BlauWI, RomerE. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.Bone Marrow Transplant1998; 22: 61–65.
55.
GelberAC, NousariHC, WigleyFM.Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases.J Rheumatol2000; 27: 1542–1545.
56.
TauscheAK, MeurerM.Mycophenolate mofetil for dermatomyositis.Dermatology2001; 202: 341–343.
57.
WaldmanMA, CallenJP.Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura.J Am Acad Dermatol2004; 51: 667–669.
58.
NousariHC, GoyalS, AnhaltGJ.Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.Arch Dermatol1999; 135: 1420–1421.
59.
FrielingU, BonsmannG, SchwarzT, LugerTA, BeissertS.Treatment of severe lichen planus with mycophenolate mofetil.J Am Acad Dermatol2003; 49: 1063–1066.
HusseinMM, MooijJM, RoujoulehHM.Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead.Nephrol Dial Transplant2000; 15: 1103–1104.
62.
GomezE, AguadoS, RodriguezM, Alvarez-GrandeJ.Kaposi's sarcoma after renal transplantation - disappearance after reduction of immunosuppression and reappearance 7 years later after start of mycophenolate mofetil treatment.Nephrol Dial Transplant1998; 13: 3279–3280.
SatchellAC, BarnetsonRS.Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate.Br J Dermatol2000; 143: 202–203.
76.
NeytsJ, De ClercqE.Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.Antiviral Res1998; 40: 53–56.
77.
GimenezF, FoeilletE, BourdonO. Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.Clin Pharmacokinet2004; 43: 685–692.
78.
NousariHC, AnhaltGJ.The role of mycophenolate mofetil in the management of pemphigus.Arch Dermatol1999; 135: 853–854.
